CB

Chander Bhan Singh

Director Director DIN 05315329
DIN 05315329 First appointment Jul 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2012
Shareholding value Locked Premium profile

About Chander Bhan Singh

Data last updated:

Chander Bhan Singh has 14 years in corporate governance. Formerly with 1 company, such as Ramadico Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05315329
Primary Designation Director
First Appointment 23 Jul 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director23 Jul 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ramadico Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chander Bhan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chander Bhan Singh

Chander Bhan Singh has 14 years in corporate governance. Formerly with 1 company, such as Ramadico Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Chander Bhan Singh is associated with 0 companies as a director.

Chander Bhan Singh has expertise in General Business.

Chander Bhan Singh has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available